Picture loading failed.

Genemedi produces core diagnostic ingredients for test of Cardiovascular disease (metabolic syndrome, atherosclerosis, insulin resistance and low-grade inflammation) and related syndrome.

GeneMedi offers paired anti-Human Fatty Acid Binding Protein (HFABP) antibodies (monoclonal antibody, mab) and Human Fatty Acid Binding Protein (HFABP) antigens (Carrier-coupled antigen, immunogen, hapten-carrier conjugates, BSA-conjugated, OVA-conjugated, KLH-conjugated) for Cardiovascular disease (metabolic syndrome, atherosclerosis, insulin resistance and low-grade inflammation) rapid test kit of Human Fatty Acid Binding Protein (HFABP) testing in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. The carrier-coupled antigens of small molecules can act as immunogens.

The fatty acid binding proteins (FABPs) are a family of transport proteins for fatty acids and other lipophilic substances such as eicosanoids and retinoids. These proteins are thought to facilitate the transfer of fatty acids between extracellular and intracellular membranes. FABP4 has been associated with several components of metabolic syndrome, atherosclerosis, insulin resistance and low-grade inflammation, and thus, it has been proposed as a cardiometabolic predictor for cardiovascular disease.

Order information

Catalog No. Description Price(In USD) Qty (Quantity) Sum(In USD)
GMP-SMT-HFABP-Ag01 BSA-Human Fatty Acid Binding Protein (HFABP);

Size:1mg

756
GMP-SMT-HFABP-Ag01 BSA-Human Fatty Acid Binding Protein (HFABP);

Size:10mg

5292
GMP-SMT-HFABP-Ag01 BSA-Human Fatty Acid Binding Protein (HFABP);

Size:100mg

37044
GMP-SMT-HFABP-Ag02 OVA-Human Fatty Acid Binding Protein (HFABP);

Size:1mg

756
GMP-SMT-HFABP-Ag02 OVA-Human Fatty Acid Binding Protein (HFABP);

Size:10mg

5292
GMP-SMT-HFABP-Ag02 OVA-Human Fatty Acid Binding Protein (HFABP);

Size:100mg

37044
GMP-SMT-HFABP-Ab01 Anti-Human Fatty Acid Binding Protein (HFABP) mouse monoclonal antibody (mAb);

Size:1mg

1953
GMP-SMT-HFABP-Ab01 Anti-Human Fatty Acid Binding Protein (HFABP) mouse monoclonal antibody (mAb);

Size:10mg

13671
GMP-SMT-HFABP-Ab01 Anti-Human Fatty Acid Binding Protein (HFABP) mouse monoclonal antibody (mAb);

Size:100mg

95697
GMP-SMT-HFABP-Ab/Ag-xmg Size≥100mg Inquiry
Shipping Cost: 760.00
Total:



Description


BSA-Human Fatty Acid Binding Protein (HFABP)

Cat No. GMP-SMT-HFABP-Ag01
Product Name BSA-Human Fatty Acid Binding Protein (HFABP)
Target Human Fatty Acid Binding Protein (HFABP)
Expression platform Synthetic
Bioactivity validation Competitive immunoassay-validated hapten-carrier conjugates [BSA-Human Fatty Acid Binding Protein (HFABP)], Human Fatty Acid Binding Protein (HFABP) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in HFABP level test of Cardiovascular disease (metabolic syndrome, atherosclerosis, insulin resistance and low-grade inflammation) and related syndrome evaluation.
Products description Competitive immunoassay-validated hapten-carrier conjugates BSA-Human Fatty Acid Binding Protein (HFABP) is Synthetic
Purity High (TBD)
Application Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

OVA-Human Fatty Acid Binding Protein (HFABP)

Cat No. GMP-SMT-HFABP-Ag02
Product Name OVA-Human Fatty Acid Binding Protein (HFABP)
Target Human Fatty Acid Binding Protein (HFABP)
Expression platform Synthetic
Bioactivity validation Competitive immunoassay-validated hapten-carrier conjugates [OVA-Human Fatty Acid Binding Protein (HFABP)], Human Fatty Acid Binding Protein (HFABP) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in HFABP level test of Cardiovascular disease (metabolic syndrome, atherosclerosis, insulin resistance and low-grade inflammation) and related syndrome evaluation.
Products description Competitive immunoassay-validated hapten-carrier conjugates OVA-Human Fatty Acid Binding Protein (HFABP) is Synthetic
Purity High (TBD)
Application Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Anti-Human Fatty Acid Binding Protein (HFABP) mouse monoclonal antibody (mAb)

Cat No. GMP-SMT-HFABP-Ab01
Product Name Anti-Human Fatty Acid Binding Protein (HFABP) mouse monoclonal antibody (mAb)
Target Human Fatty Acid Binding Protein (HFABP)
Expression platform hybridoma
Isotypes Mouse IgG
Bioactivity validation Human Human Fatty Acid Binding Protein (HFABP) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in HFABP level test of Cardiovascular disease (metabolic syndrome, atherosclerosis, insulin resistance and low-grade inflammation) and related syndrome evaluation.
Tag mFc
Products description Anti-Human Fatty Acid Binding Protein (HFABP) mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by hybridoma technology.
Purity Purity: ≥95% (SDS-PAGE)
Application Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation Supplied as a 0.2 μM filtered solution of PBS, PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.